Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03776071
Title A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Denovo Biopharma LLC
Indications

glioblastoma

Therapies

Enzastaurin

Temozolomide

Enzastaurin + Temozolomide

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.